{"chebi_id":"2504","chebi_name":"aflatoxin B1","chebi_synonyms":["Aflatoxin B1","(6aR,9aS)-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene-1,11-dione","2,3,6aalpha,9aalpha-Tetrahydro-4-methoxycyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione"],"diffprof_id_observed":["MTBLS2145_0002_00000029","MTBLS2406_0001_00000009","MTBLS2945_0001_00000003","MTBLS3750_0001_00000006"],"diffprof_id_var_observed":["MTBLS2145_0002_00000029","MTBLS2406_0001_00000009"],"inchikey":"OQIQSTLJSLGHID-WNWIJWBNSA-N","inn_name":"","iupac_name":"(6a<i>R</i>,9a<i>S</i>)-4-methoxy-2,3,6a,9a-tetrahydrocyclopenta[<em>c</em>]furo[3',2':4,5]furo[2,3-<em>h</em>]chromene-1,11-dione","num_study_observed":4,"reactome_ids":["R-HSA-1430728","R-HSA-211859","R-HSA-211897","R-HSA-211945","R-HSA-211981","R-HSA-5423646"],"reactome_names":["Metabolism","Biological oxidations","Cytochrome P450 - arranged by substrate type","Phase I - Functionalization of compounds","Xenobiotics","Aflatoxin activation and detoxification"],"study_id_observed":["MTBLS2145","MTBLS2406","MTBLS2945","MTBLS3750"],"study_id_var_observed":["MTBLS2145","MTBLS2406"],"synonym_name":"2,3,6aalpha,9aalpha-Tetrahydro-4-methoxycyclopenta(c)furo(3',2':4,5)furo(2,3-h)(1)benzopyran-1,11-dione"}